Join The Discussion

 

Trademark closes on 63-acre Waterside site in Fort Worth

Construction begins Oct. 20 on the development, to be anchored by a Whole Foods Market.

read more >

UPDATE: $215M hotel, indoor ski project planned for Grand Prairie

Officials in Grand Prairie are expected later today to announce a $215 million project that will include a Hard Rock Hotel and an indoor ski facility.

read more >

Two Fort Worth council members propose temporary single-family moratorium around TCU

The moratorium would apply to new permits for single-family homes around TCU, and give the city time to figure out what to do with a controversial proposed overlay in several neighborhoods around the university.

read more >

Fresh Ebola fears hit airline stocks

DALLAS (AP) — News that a nurse diagnosed with Ebola flew on a plane full of passengers raised fear among airline investors that the scare over the virus could cause travelers to avoid flying.

read more >

Landscape architect behind several TCU landmarks acquired

The Dallas design firm behind several Texas Christian University projects, as well as Globe Life Park in Arlington and AT&T Stadium, has been acquired by Rvi Planning + Landscape Architecture.

read more >

TECH Fort Worth client receives $550,000 financing

 

Betty Dillard

bdillard@bizpress.net

Vital Art and Science Inc. (VAS), creator of the myVisionTrack home vision monitor, has completed a $550,000 Series A round of financing, the Richardson-based company announced Aug. 27.


The funding will enable VAS to continue development of its smart phone-based home monitor products and support its work with strategic partners to bring the myVisionTrack test to millions of patients around the world.
The funding round was led by the North Texas Angel Network (NTAN), and valued the company at $10 million post financing.


“The myVisionTrack home monitor is the first easy-to-use and accurate test for patients already diagnosed with a wet-AMD, or diabetic retinopathy, to monitor their disease progress and help ensure they get timely treatments to help save their vision,” said Mike Bartlett, VAS founder and president.


Bartlett said the company received its clearance from the U.S. Food and Drug Administration in February. The funding will allow VAS, a client of technology incubator TECH Fort Worth, to bring its product to market.
MyVisionTrack can be used in a physician’s office or at home by patients with these diseases to help track disease progression, detect disease condition changes for earlier intervention and document treatment effects.
 

< back

Email   email
hide
Ebola
How worried are you about Ebola spreading?